Pharmaceutical Mail. The European Commission has authorized the marketing of Benepali, the biosimilar of etanercept (whose reference product is Enbrel, from Pfizer), from Samsung Bioepis, the j between Biogen and Samsung BioLogics.
Industry news
Pharmaceutical Mail. The European Commission has authorized the marketing of Benepali, the biosimilar of etanercept (whose reference product is Enbrel, from Pfizer), from Samsung Bioepis, the j between Biogen and Samsung BioLogics.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.